Deutsche Bank
ANAC

Deutsche Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Deutsche Bank’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-203,576
Closed -$10.9M – 5660
2016
Q1 		$10.9M Sell
203,576
-22,804
-10% -$1.68M 0.01% 1207
2015
Q4 		$25.6M Sell
226,380
-165,848
-42% -$18.3M 0.02% 823
2015
Q3 		$46.2M Buy
392,228
+162,613
+71% +$21.2M 0.04% 511
2015
Q2 		$17.8M Sell
229,615
-61,892
-21% -$4.06M 0.01% 994
2015
Q1 		$16.9M Buy
291,507
+49,347
+20% +$2.09M 0.01% 1021
2014
Q4 		$7.81M Sell
242,160
-18,467
-7% -$554K ﹤0.01% 1623
2014
Q3 		$6.38M Buy
260,627
+84,970
+48% +$1.73M ﹤0.01% 1655
2014
Q2 		$3.11M Sell
175,657
-12,715
-7% -$205K ﹤0.01% 2161
2014
Q1 		$3.77M Buy
188,372
+28,135
+18% +$546K ﹤0.01% 2018
2013
Q4 		$2.69M Sell
160,237
-30,836
-16% -$427K ﹤0.01% 2120
2013
Q3 		$2.03M Buy
191,073
+118,671
+164% +$1.04M ﹤0.01% 2488
2013
Q2 		$403K Buy
+72,402
New +$438K ﹤0.01% 3308

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Deutsche Bank's ANAC Position: Q2 2016 in Review

Deutsche Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 203,576 shares — an estimated $10.9M sold.

Deutsche Bank first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $46.2M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Deutsche Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Deutsche Bank sold 203,576 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $10.9M.
  • Deutsche Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Deutsche Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $46.2M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Deutsche Bank's 13F filing for Q2 2016, filed 15 Aug 2016.